Press Releases :: Soliton, Inc. (SOLY)

Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device

Mar 21, 2019

Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication

Mar 19, 2019

Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019

Mar 18, 2019

Soliton Partners with Sanmina, a Global Medical Device Manufacturer

Mar 14, 2019

Soliton to Ring the Nasdaq Stock Market Closing Bell on March 19, 2019

Mar 12, 2019

Soliton's RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation

Mar 8, 2019

Soliton Receives FDA Approval for Small Business Designation

Mar 4, 2019

Soliton Discusses Rapid Acoustic Pulse Technology for Treatment of Cellulite

Feb 28, 2019

Soliton Receives Additional Patent for Breakthrough Acoustic Shockwave Technology

Feb 26, 2019

Soliton, Inc. Completes IPO and Begins Trading on Nasdaq Under Ticker Symbol “SOLY”

Feb 19, 2019

First Name*
First
Email*
Cell (Optional: Used For Press Releases)

© 2021 Soliton Inc. All Rights Reserved, Soliton Inc.